Form 4: Armata Pharmaceuticals CEO Reports Stock Transaction
Insider Transaction (Form 4)
Deborah Birx, Chief Executive Officer and a Director of Armata Pharmaceuticals, Inc., reported a transaction in 14,041 shares of common stock on July 10, 2026.
Summary
- Tax/exercise-price withholding: disposed of 14,041 Common Stock at $4.26 ($59,815) on July 10, 2026; holds 198,417 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Deborah Birx — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-10 | Tax/exercise-price withholding | Common Stock | 14,041 | $4 | $59.8K | 198,417 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-10 | Tax/exercise-price withholding (14,041 shares) |
Keywords
insider transaction, Form 4, ARMP, Armata Pharmaceuticals, Inc., neutral, Deborah Birx
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.